Comparison of circulating lipid profiles, D-dimer and fibrinogen levels between hypertensive patients with and

Endeshaw Chekol Abebe1, Misganaw Asmamaw Mengstie1, Mohammed Abdu Seid2

  • 1Department of Biochemistry, College of Health Science, Debre Tabor University, Debre Tabor, Ethiopia.

Metabolism Open
|August 10, 2023
PubMed

Insights

Hypertensive patients with stroke show higher lipid, fibrinogen, and D-dimer levels. Total cholesterol, D-dimer, and fibrinogen predict stroke risk in this population, highlighting dyslipidemia and hemostatic activation roles.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Clinical Biochemistry

Background:

  • Stroke is a major cause of death and disability, especially in individuals with hypertension.
  • Hypertension is a significant risk factor for stroke, necessitating research into associated biomarkers.
  • Understanding these biomarkers can aid in stroke prevention and management strategies.

Purpose of the Study:

  • To compare lipid profiles, fibrinogen, and D-dimer levels in hypertensive patients with and without stroke.
  • To identify predictors of stroke among hypertensive patients.

Main Methods:

  • A cross-sectional study involving 115 hypertensive patients (45 with stroke, 70 without).
  • Data collected from November 2022 to January 2023 at Yikatit 12 Hospital Medical College, Ethiopia.
  • Statistical analyses included Chi-square, t-tests, Mann-Whitney U, and multiple logistic regression.

Main Results:

  • Hypertensive patients with stroke had significantly higher levels of Total Cholesterol (TC), LDL-C, D-dimer (D-DI), and fibrinogen compared to those without stroke.
  • TC, D-DI, and fibrinogen were identified as independent predictors of stroke in hypertensive patients.
  • Ischemic stroke patients exhibited higher mean TC, D-DI, and fibrinogen levels than hemorrhagic stroke patients.

Conclusions:

  • Elevated TC, LDL-C, D-DI, and fibrinogen are associated with stroke in hypertensive individuals.
  • TC, D-DI, and fibrinogen are significant predictors of stroke in this patient group.
  • Findings underscore the roles of dyslipidemia and hemostatic activation in stroke development, particularly ischemic stroke.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
27
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
194
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
119
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
14
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
13
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
17